Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlob Disrupt Pf Regulatory News (FWD)

Share Price Information for Glob Disrupt Pf (FWD)

Share Price is delayed by 15 minutes
Get Live Data
15.802    0.054 (0.34%)
Bid:
15.778
Ask:
15.826
Spread: 0.048 (0.304%)
Market Cap: -
FWD Live PriceLast checked at - London Stock Exchange

Intraday Glob Disrupt Pf Share Chart

Form 8.5 (EPT/RI)

8 Mar 2024 10:06

RNS Number : 1665G
Liberum Capital Limited
08 March 2024
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Forward Partners Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Forward Partners Group plc

(d) Date dealing undertaken:

7th March 2024

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 1p

 

 

Purchase

 

10,000

 

0.27

 

0.27

 

ORD 1p

 

 

Sale

 

7,025

 

0.285

 

0.285

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

8th March 2024

Contact name:

Shivani Ghiraiya

Telephone number:

020 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERBGGDXSGGDGSI
12
Date   Source Headline
7th Dec 202310:15 amRNSForm 8 (OPD) (Forward Partners Group plc)
7th Dec 20239:05 amRNSForm 8.5 (EPT/RI)
5th Dec 20239:14 amRNSForm 8.5 (EPT/RI)
4th Dec 20239:40 amRNSForm 8.5 (EPT/RI)
29th Nov 20238:44 amRNSForm 8.5 (EPT/RI)
28th Nov 20231:25 pmRNSForm 8.3 - Forward Partners Group PLC
28th Nov 202310:47 amGNWForm 8.3 - [Forward Partners Group plc - Opening Disclosure - 27 11 2023] - (CGAML)
28th Nov 20239:52 amRNSForm 8.5 (EPT/RI)
27th Nov 20237:00 amRNSRule 2.7 Recommended All-Share Acquisition
28th Sep 20237:00 amRNSInterim Results
24th Jul 20237:00 amRNSPortfolio Update
27th Jun 20233:49 pmRNSResults of 2023 Annual General Meeting
16th Jun 20234:36 pmRNSLTIP Awards and Director's Dealing
2nd Jun 20237:00 amRNSNotice of 2023 AGM
4th May 20237:00 amRNSFinal Results
28th Mar 20232:56 pmRNSChange of Registered Office
27th Feb 20237:00 amRNSFull Year Trading Update
22nd Feb 20234:27 pmRNSDirector Declaration
13th Jan 202311:51 amRNSARENA JOINS FORWARD PORTFOLIO AFTER PATCH MERGER
12th Jan 20237:00 amRNS£1m investment in Hospitality Management Platform
8th Dec 20229:00 amRNSPortfolio Update
2nd Nov 20223:00 pmRNSLTIP Awards and Director's Dealing
13th Oct 20227:00 amRNSNotice of Investor Event
22nd Sep 20227:00 amRNSInterim results six months to 30 June 2022
14th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 20227:00 amRNSTrading Update
15th Aug 20222:27 pmRNSResult of AGM
25th Jul 20227:00 amRNSPortfolio Update
14th Jul 20227:00 amRNSNotice of 2022 AGM
8th Jul 20227:00 amRNSCASH REALISATION FOLLOWING DISPOSAL OF SHARES
30th Jun 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSTrading Update and Update on FY21 Results
6th Apr 20227:00 amRNSRelated Party Transaction
10th Mar 20227:00 amRNSChange of Registered Office
28th Feb 20227:00 amRNSFull Year Trading Update and Notice of Results
24th Feb 20227:00 amRNSPortfolio Update
17th Jan 20227:00 amRNSAppointment of new Group Chief Financial Officer
6th Jan 20229:32 amRNSEstablishment of LTIP and Grant of Options
29th Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSPortfolio Valuation Increase
12th Aug 20217:00 amRNSPortfolio Exits and New Investments
19th Jul 20217:00 amRNSAdmission to AIM and first day of dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.